Current Employee -- IMS Acquisition ruined Quintiles's Legacy. - Clinical Ops IQVIA Employee Review

3.0
Jan 23, 2018
Recommend
CEO approval
Business Outlook

Pros

Flexible working schedule Independence (depends on the role) Caring employees (Quintiles)

Cons

The acquisition has only benefited the IMS upper executives, namely Ari Boubsib and IMS board members. Benefits have been slashed to the bare bone making Quintiles one of the best place to work for to the least desirable; this coupled with below industry average pay, zero work life balance, and constant policy change is causing everyone to jump ship. IMS (namely Ari) has no idea of managing a CRO and is attempting, very poorly, to implement tech firm strategies to run a large CRO. Employee morale is extremely low and advancement has been non existent. Regionalization has pitted one group of management against each other, putting employees in the middle, only to jeopardize quality of work. Most IT support has been offshored overseas rendering support completely useless. The new company policy is to minimize cost at all fronts so Ari can justify his 40 million dollar salary.

Explore other reviews about IQVIA

5.0
May 12, 2026
Recommend
CEO approval
Business Outlook

Pros

good learning opportunity and a stepping stone

Cons

sponsor driven, sloe promotions, decent pay

3.0
Jun 25, 2026
Recommend
CEO approval
Business Outlook

Pros

The team was great to work with and the general work environment was hard to beat

Cons

It felt like sales and upper management completely dropped the ball with our product. We had what could have been a large success in the market but we were too ignored to really push ourselves towards new customers. Pretty much the whole team was laid off as a result.

See reviews by: Helpful|Rating|Date|All